Fu‐Ming Tsai
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 10%
Papers in
-
- Tryptophan and brain disorders 5
- Urology 4
- Hair Growth and Disorders 4
- Co-authors
- Mao‐Liang ChenRong‐Yaun ShyuLu‐Kai WangShun‐Yuan JiangTzung‐Chieh TsaiChang‐Chieh WuChun‐Hua WangChan‐Yen Kuo
- Journals
- Indian Journal of Pharmaceutical Sciences (4 papers)Evidence-based Complementary and Alternative Medicine (4 papers)Immunopharmacology and Immunotoxicology (3 papers)International Immunopharmacology (3 papers)BioMed Research International (3 papers)
- Partner nations
- TaiwanUnited StatesRussia
In The Last Decade
Fu‐Ming Tsai
57 papers receiving 890 citations
Peers
Comparison fields: 5 of 127
- Biological Psychiatry 113
- Behavioral Neuroscience 33
- Cancer Research 121
- Immunology 167
- Neurology 56
Countries citing papers authored by Fu‐Ming Tsai
This map shows the geographic impact of Fu‐Ming Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu‐Ming Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu‐Ming Tsai more than expected).
Fields of papers citing papers by Fu‐Ming Tsai
This network shows the impact of papers produced by Fu‐Ming Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu‐Ming Tsai. The network helps show where Fu‐Ming Tsai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fu‐Ming Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 0 | |
| 10 | 2020 | 75 | |
| 11 | 2020 | 22 | |
| 12 | 2019 | 15 | |
| 13 | 2019 | 4 | |
| 14 | 2016 | 11 | |
| 15 | 2012 | 24 | |
| 16 | 2012 | 35 | |
| 17 | 2009 | 28 | |
| 18 | 2007 | 28 | |
| 19 | RIG1 inhibits the Ras/mitogen activated protein kinase pathway by suppression the activation of Ras | 2005 | 1 |
| 20 | 2005 | 42 |
About Fu‐Ming Tsai
Fu‐Ming Tsai is a scholar working on Biological Psychiatry, Urology, Immunology, Immunology and Allergy and Molecular Biology, having authored 59 papers that have together received 903 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (9 papers), Ubiquitin and proteasome pathways (9 papers), Tryptophan and brain disorders (5 papers), interferon and immune responses (4 papers), Hair Growth and Disorders (4 papers), Microtubule and mitosis dynamics (4 papers), Cellular Mechanics and Interactions (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Biological Psychiatry (113 citations), Behavioral Neuroscience (33 citations), Cancer Research (121 citations), Immunology (167 citations) and Neurology (56 citations). Fu‐Ming Tsai has collaborated with scholars based in Taiwan, United States and Russia. Frequent co-authors include Mao‐Liang Chen, Rong‐Yaun Shyu, Lu‐Kai Wang, Shun‐Yuan Jiang, Tzung‐Chieh Tsai, Chang‐Chieh Wu, Chun‐Hua Wang, Chan‐Yen Kuo, Ya‐Min Tsai and Ming‐Cheng Lee. Their work appears in journals such as Indian Journal of Pharmaceutical Sciences, Evidence-based Complementary and Alternative Medicine, Immunopharmacology and Immunotoxicology, International Immunopharmacology and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.